亚洲综合中文字线观看看,中文欧美亚洲欧日韩一,2020年国产精品自线在拍,亚洲AⅤ日韩AV电影在线观看

      1. <dfn id="lnb6s"><var id="lnb6s"></var></dfn>

        1. Chinese researchers use AI to explore diabetes classification

          Source: Xinhua| 2019-01-10 19:05:25|Editor: Xiang Bo
          Video PlayerClose

          BEIJING, Jan. 10 (Xinhua) -- Chinese researchers are using artificial intelligence (AI) to classify different types of diabetes, which may help Chinese patients obtain more precise treatment.

          Different types of diabetes require diverse treatment. The current diabetes classification system, which has been used for more than 20 years is based on cause and pathological?features, which has limitations in guiding clinical treatment.

          Researchers from Peking University People's Hospital are working on a more elaborate classification of diabetes that may support individualized treatment.

          They conducted research on diabetes classification based on the data of 2,316 Chinese people newly diagnosed with diabetes and 815 Americans.

          Using the AI clustering method, they separate the two groups into four diabete subtypes based on five variables including age, BMI, blood glucose levels and insulin resistance indexes.

          According to Zou Xiantong, one of the researchers, a previous study from Northern Europe has used similar methods to divide diabetes into five subgroups and demonstrated that the subgroups have different clinical manifestations and corresponding treatments. However, all cases involved in the study were from Northern Europe, and it is unknown whether it is applicable to other populations.

          "We hope our research may provide data support for more accurate typing and treatment of diabetes in the Chinese population," Zou said.

          The data analysis showed that the main clinical features of the four subtypes were basically consistent in the Chinese and U.S. groups, which also coincided with the subtype characteristics of the Northern Europe research.

          The research was published in the journal The Lancet Diabetes and Endocrinology.

          TOP STORIES
          EDITOR’S CHOICE
          MOST VIEWED
          EXPLORE XINHUANET
          010020070750000000000000011100001377340951